We are live on ! Find out more
CDH

Charles D. Hyman Portfolio holdings

AUM $1.79B
1-Year Est. Return 17.18%
This Fund
S&P 500
This Quarter Est. Return
+4.32%
1 Year Est. Return
+17.18%
3 Year Est. Return
+36.79%
5 Year Est. Return
+95.96%
10 Year Est. Return
+199.04%
AUM
$958M
AUM Growth
-$14.4M
Cap. Flow
-$46.7M
Cap. Flow %
-4.88%
Top 10 Hldgs %
33.58%
Holding
201
New
12
Increased
73
Reduced
53
Closed
12

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.47M
2
DOW icon
Dow Inc
DOW
+$762K
3
IBM icon
IBM
IBM
+$744K
4
AAPL icon
Apple
AAPL
+$632K
5
VMC icon
Vulcan Materials
VMC
+$503K

Sector Composition

Rank Sector Weight
1 Industrials 22.55%
2 Financials 14.73%
3 Technology 11.23%
4 Consumer Staples 8.87%
5 Healthcare 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHC icon
176
Graham Holdings Company
GHC
$4.97B
$221K 0.02%
+320
New +$223K
GSK icon
177
GSK
GSK
$103B
$220K 0.02%
+4,400
New +$221K
STI
178
DELISTED
SunTrust Banks, Inc.
STI
$220K 0.02%
3,493
+50
+1% +$3.14K
LION
179
DELISTED
Fidelity Southern Corporation
LION
$219K 0.02%
+7,056
New +$206K
TMO icon
180
Thermo Fisher Scientific
TMO
$211B
$216K 0.02%
735
TFX icon
181
Teleflex
TFX
$5.85B
$215K 0.02%
+650
New +$196K
HSY icon
182
Hershey
HSY
$35.4B
$214K 0.02%
+1,600
New +$203K
BLK icon
183
Blackrock
BLK
$164B
$202K 0.02%
+430
New +$195K
ARCC icon
184
Ares Capital
ARCC
$13.5B
$189K 0.02%
10,510
CHI
185
Calamos Convertible Opportunities and Income Fund
CHI
$1.02B
$173K 0.02%
16,500
MTNB icon
186
Matinas BioPharma
MTNB
$1.55M
$68K 0.01%
1,596
LEE icon
187
Lee Enterprises
LEE
$166M
$42K ﹤0.01%
1,865
CHK
188
DELISTED
Chesapeake Energy Corporation
CHK
$39K ﹤0.01%
100
SMRT
189
DELISTED
Stein Mart Inc
SMRT
$21K ﹤0.01%
25,000
-13,500
-35% -$12.3K
GEOS icon
190
Geospace Technologies
GEOS
$91.6M
-13,100
Closed -$170K
GIFI
191
DELISTED
Gulf Island Fabrication
GIFI
-11,800
Closed -$108K
GS.PRA icon
192
Goldman Sachs Group Inc Depositary Shares
GS.PRA
$570M
-624,424
Closed -$11.9M
KHC icon
193
Kraft Heinz
KHC
$30.4B
-27,617
Closed -$902K
MET.PRA icon
194
MetLife Inc Floating Rate Series A
MET.PRA
$504M
-731,290
Closed -$16.5M
MS.PRA icon
195
Morgan Stanley Series A Preferred Stock
MS.PRA
$760M
-295,255
Closed -$5.71M
MS.PRK icon
196
Morgan Stanley Series K Preferred Stock
MS.PRK
$918M
-52,500
Closed -$1.34M
MS.PRI icon
197
Morgan Stanley Series I Preferred Stock
MS.PRI
$991K
-166,065
Closed -$4.43M
NCV
198
Virtus Convertible & Income Fund
NCV
$374M
-2,650
Closed -$69K
BBT.PRD.CL
199
DELISTED
BB&T CORPORATION Depositary Shares, representing 1/1,000th interest in a share of Series D Non-Cumul
BBT.PRD.CL
-98,430
Closed -$2.48M
GS.PRB.CL
200
DELISTED
Goldman Sachs Group Depositary Shares (1/1000 Interest of 6.2% Non-Cum. Prfrd. Stock, Series B) Call
GS.PRB.CL
-8,545
Closed -$233K

Similar funds

Charles D. Hyman's Q2 2019 Portfolio in Review

As of Q2 2019, Charles D. Hyman held 201 positions worth $958M, down 1.5% from $973M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Charles D. Hyman withdrew a net $46.7M in Q2 2019, closing 12 positions and reducing 53 holdings. Its most notable exit was MetLife Inc Floating Rate Series A, an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

Against the trend, Charles D. Hyman opened a new position in Dow Inc worth $712K.

  • Charles D. Hyman's largest Q2 2019 buy was Dow Inc: 14,435 shares worth $712K.
  • Charles D. Hyman added most to Berkshire Hathaway Class B in Q2 2019, an estimated $1.47M increase.
  • Charles D. Hyman's biggest Q2 2019 reduction was Boeing, cutting an estimated $1M.
  • Charles D. Hyman fully exited MetLife Inc Floating Rate Series A in Q2 2019, selling an estimated $16.5M.
  • Charles D. Hyman's ten largest holdings make up 34% of its $958M portfolio in Q2 2019.
  • Charles D. Hyman opened 12 new positions and closed 12 in Q2 2019.
  • Charles D. Hyman's portfolio value fell 1.5% quarter-over-quarter to $958M.

Based on Charles D. Hyman's 13F filing for Q2 2019, filed 24 Jul 2019.